Market Overview

Epizyme Announces FDA Acceptance of Investigational New Drug Application for Tazemetostat in Mesothelioma

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Related Articles (EPZM)

Partner Center

Loading...